Africa Biosystems Limited (ABL) demonstrated its commitment to growing the Life Sciences sector in East Africa by opening an office in Dar-es-Salaam. Managing Director Yasmin Verjee says “the goal is to improve our response time to our growing client base and to be the leader in molecular biology applications and technological transfer in research, academia and medical diagnostic support.”
The ABL team, including Johnny Verjee and John Mwakio, hosted the launch event. In attendance were representatives from Nelson Mandela African Institute, CDC TZ,Tanzania Commission For Science and Technology, among others.
We will be promoting a range of products including instruments and consumables across molecular workflows and an analytical range of instruments in the field of Mass spectrometry, chromatography and analytics.
Demand for ABL services in Tanzania is growing and the Dar office is a response to that. “We not only supply the instruments but offer after sales service that include, instrument installation, maintenance and training support across different molecular applications. Our model of business is an end-to-end solutions partnership that values successful outcomes which benefit communities where we operate and beyond,” says Verjee.
We are a life sciences company with products and services across the spectrum of research, Medical Diagnostics and applied sciences. ABL is also a member of the United Nations Global Compact whose business policy is guided by the universal principle of Human rights, respect to labor rules, sensitivity to environment and anti-corruption practice.
Africa Biosystems represents the world leader in Serving Sciences Thermo Fisher Scientific- Life Science solutions division. Africa Biosystems is currently present in seven countries in the region namely Kenya, Uganda, Ethiopia, Eritrea, Rwanda, Burundi and Tanzania with regional offices in Nairobi, Kampala and now Dar-es-Salaam.